Frick, M H <br/><br/>
Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.  [electronic resource] 

 -  The American journal of cardiology  May 1987 
 - 61G-67G p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/0002-9149(87)90159-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-Antagonists--therapeutic use<br/>Adult<br/>Aged<br/>Antihypertensive Agents--therapeutic use<br/>Atenolol--therapeutic use<br/>Clinical Trials as Topic<br/>Double-Blind Method<br/>Doxazosin<br/>Female<br/>Heart Rate--drug effects<br/>Humans<br/>Hypertension--blood<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Prazosin--analogs & derivatives<br/>Random Allocation<br/>Time Factors